Skip to main content
Eli Lilly and Company logo

Eli Lilly and Company

Strategic / Corporate InvestorLilly Corporate Center, United StatesSee on the maplilly.com

pharmahealthcareclinical trials

Eli Lilly and Company is a medicine company that develops and provides medicines and supports clinical trials across conditions including Alzheimer's disease, cancer, diabetes, and migraine.

3
Portfolio companies on reccy
1
Hiring now
12
Open roles in the portfolio
Jul 2026
Latest portfolio round

Hiring now in the portfolio12

See every role on each company's page

Portfolio on reccy3

Their companies, round by round

  • Alto NeuroscienceLos Altos, CA
    • Jul 2026Post-IPO Equity (PIPE) · $100M
    • Mar 2026Post-IPO Equity (PIPE) · $120M
    • Oct 2025Post-IPO Equity (PIPE) · $50M
    • Jul 2024Grant · $11.7M
    • Nov 2023Venture Round · $59.3M
    • Nov 2023Series C · $45MLed
  • ŌURAHelsinki, Finland; Oulu, Finland; San Francisco, CA; San Diego, CA

    Wearables

    • Jul 2026Series E
    • Jul 2026CorporateLed
    • Oct 2025Series E · $900M
    • Sep 2025Debt · $250M
    • Nov 2024Series D · $200M
    • Apr 2022Venture Round
  • RetiSpecToronto, Ontario, Canada
    • Sep 2024Accelerator/Incubator
    • Jul 2024Series A · $10MLed
    • Apr 2023Grant
    • Nov 2020Accelerator/Incubator
    • Feb 2020Seed
    • Nov 2019Seed · $250K

Rounds marked Led list Eli Lilly and Company as a lead investor; the rest are the company's other funding.

Recent rounds in the portfolio

Portfolio in the news